NOT-MD-20-028: Notice of NIMHD Participation in PAR-20-302, "Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)"

Notice of NIMHD Participation in PAR-20-302, "Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)"

Notice Number:

NOT-MD-20-028

Key Dates

Release Date:

September 24, 2020

Related Announcements

PAR-20-302 - Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)

Issued by

National Institute on Minority Health and Health Disparities (NIMHD)

Purpose

This Notice informs potential applicants that the National Institute on Minority Health and Health Disparities (NIMHD) is participating, effective immediately, in PAR-20-302, "Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional)."

The following changes are made to PAR-20-302 (shown in italics) to reflect NIMHD's participation in this FOA.

Part 1. Overview Information

Components of Participating Organizations

National Cancer Institute (NCI)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

National Institute on Minority Health and Health Disparities (NIMHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.395, 93.307

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)

Priscah Mujuru, Dr.PH, MPH, RN
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-9765
Email:[email protected]

Financial/Grants Management Contact(s)

Priscilla Grant, JD
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-8412
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Priscah Mujuru, Dr.PH, MPH, RN
National Institute on Minority Health and Health Disparities (NIMHD)
Telephone: 301-594-9765
Email: [email protected]